In line with these results, and contrarily to the majority of the available literature, a recent report on MCF-7 and MDA-MB-231 breast cancer cells showed that RGN expression was augmented along with tumour undifferentiation through a mechanism that seems to be mediated by the activation of the ERK/MAPK signalling pathway [76]. Here, RGN is linked to breast carcinoma.